art_27__para
The Committee for Veterinary Medicinal Products established by Article 16 of Directive 81/851/EEC, in this Title referred to as 'the Committee', shall be responsible for formulating the opinion of the Agency on any question concerning the admissibility of the files submitted in accordance with the centralized procedure, the granting, variation, suspension or withdrawal of an authorization to place a veterinary medicinal product on the market arising in accordance with the provisions of this Title and pharmacovigilance.
← Article 27 · All articles · Article 28 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.